Thyroid Gland Anaplastic Carcinoma

9 clinical trials · Condition

Record	Firm	Date
Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer (NCT04675710)	M.D. Anderson Cancer Center	2021-06-24
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer (NCT04759911)	M.D. Anderson Cancer Center	2021-02-26
Dabrafenib and Trametinib Combination as a Neoadjuvant Strategy in BRAF-positive Anaplastic Thyroid Cancer (NCT04739566)	Saint Petersburg State University, Russia	2021-01-22
Dabrafenib, Trametinib, and IMRT in Treating Patients With BRAF Mutated Anaplastic Thyroid Cancer (NCT03975231)	City of Hope Medical Center	2020-09-14
LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas (NCT03449108)	M.D. Anderson Cancer Center	2018-04-27
Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer (NCT03181100)	M.D. Anderson Cancer Center	2017-07-27
Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer (NCT01236547)	National Cancer Institute (NCI)	2010-10-28
Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer (NCT00625846)	National Cancer Institute (NCI)	2008-02-22

Every clearance here is in the API, with alerts when new ones post.